Epoetin Alfa: all 215 studies that test it
Page 1 of 3. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Effect of Daprodustat and Epoetin Alpha on Anemia in Patients Not Undergoing DialysisNot yet recruitingNCT07755683Not applicable
- Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center HemodialysisNot yet recruitingNCT07565701Phase 3
- Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.Not yet recruitingNCT07296146Phase 3
- PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).RecruitingNCT07025681Phase 3
- Pharmacokinetics, Pharmacodynamics, and Safety of NANOKINE Compared With Eprex 4000 U in Healthy VolunteersNot yet recruitingNCT06919861Phase 1
- EVR and EPO for Liver Transplant ToleranceRecruitingNCT06832189Phase 1
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)RecruitingNCT05564390Phase 2
- Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESARecruitingNCT05181735Phase 1/2
- ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA PatientsRecruitingNCT04588311Phase 3
- Impact of Erythropoietin on Hematological Adaptations and Physical PerformanceCompletedNCT05078138Phase 4Results posted
- Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney DiseaseCompletedNCT04036253Phase 3Results posted
- Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy VolunteersCompletedNCT03822884Phase 1Results posted
- Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis PatientsCompletedNCT02817555Phase 4Results posted
- EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)TerminatedNCT02802592Phase 1/2Results posted
- Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control TrialTerminatedNCT02564796Phase 2Results posted
- A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT02504294Phase 3Results posted
- Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedNCT02253654Phase 4Results posted
- Active Preoperative Anemia Management in Patients Undergoing Cardiac SurgeryTerminatedNCT02189889Phase 1/2Results posted
- Optimized Erythropoietin (EPO) TreatmentCompletedNCT02075970Phase 2Results posted
- The Benefits of a Preoperative Anemia Management ProgramTerminatedNCT01888003Not applicableResults posted
- Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving HemodialysisTerminatedNCT01737879Phase 4Results posted
- A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With EpoetinCompletedNCT01628120Phase 3Results posted
- A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01628107Phase 3Results posted
- HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)CompletedNCT01576341Phase 3Results posted
- Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedNCT01478971Phase 3Results posted
- A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473420Phase 3Results posted
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473407Phase 3Results posted
- A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related AnemiaCompletedNCT01394991Phase 4Results posted
- Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)CompletedNCT01378273Phase 3Results posted
- Randomized Study of Weekly Erythropoietin Dosing in Preterm InfantsCompletedNCT01235923Phase 2Results posted
- Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation ChemotherapyCompletedNCT01099202Not applicableResults posted
- Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin LymphomasCompletedNCT01030900Phase 2Results posted
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)TerminatedNCT00924781Phase 2Results posted
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and AnemiaActive, not recruitingNCT00843882Phase 3Results posted
- Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer PatientsCompletedNCT00711958Phase 3Results posted
- Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis PatientsTerminatedNCT00701714Phase 3Results posted
- A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for TransfusionTerminatedNCT00695396Phase 3Results posted
- A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDSCompletedNCT00656448Phase 3Results posted
- Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.CompletedNCT00632125Phase 4Results posted
- Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin AlfaTerminatedNCT00626574Phase 4Results posted
- Erythropoetin Neuroprotection for Neonatal Cardiac SurgeryCompletedNCT00513240Phase 1/2Results posted
- Prevalence and Treatment of Anemia in Rehabilitation PatientsTerminatedNCT00511901Phase 4Results posted
- An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney DiseaseCompletedNCT00440557Phase 3Results posted
- PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD PatientsCompletedNCT00440466Phase 3Results posted
- Erythropoietin (EPO) and Ischemia-reperfusion After Kidney TransplantationCompletedNCT00425698Phase 2/3Results posted
- Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyCompletedNCT00416624Phase 2Results posted
- Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple MyelomaCompletedNCT00400686Not applicableResults posted
- A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving ChemotherapyTerminatedNCT00386152Phase 2Results posted
- Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial InfarctionCompletedNCT00367991Phase 2Results posted
- The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic SurgeryTerminatedNCT00350519Phase 4Results posted
- A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.CompletedNCT00337935Phase 2Results posted
- Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal DialysisCompletedNCT00236938Phase 3Results posted
- Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin AlfaTerminatedNCT00210626Phase 2Results posted
- EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell LymphomaCompletedNCT00114738Phase 2Results posted
- Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell LymphomasCompletedNCT00069238Phase 2Results posted
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerCompletedNCT00014222Phase 3Results posted
- EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV InfectionCompletedNCT00006436Phase 2Results posted
- Treatment and Natural History Study of Lymphomatoid GranulomatosisCompletedNCT00001379Phase 2Results posted
- The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and FemalesStatus unknownNCT04965961Not applicable
- Desidustat in the Treatment of Anemia in CKD on Dialysis PatientsCompletedNCT04215120Phase 3
- CD71 in Dried Blood Spots in Healthy MalesCompletedNCT04073849Early Phase 1
- Erythropoietin Protects Very Preterm Infants Against Necrotizing EnterocolitisCompletedNCT03919500Phase 2
- Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.CompletedNCT03572647Phase 1
- Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted AnemiaTerminatedNCT03528564Phase 2
- Fish Oil and EPO in Breast CancerStatus unknownNCT03516253Not applicable
- Intravenous Treatment of Anemia in PregnancyCompletedNCT03317210Phase 4
- Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating AgentsStatus unknownNCT03276910Phase 1
- A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDSActive, not recruitingNCT03223961Phase 3
- PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in NewbornsCompletedNCT03079167Phase 3
- Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)CompletedNCT02947438Phase 3
- Generation of Positive Biological Samples to Epoetin for Doping Control.CompletedNCT02920372Phase 1
- Study to Compare the Safety and Efficacy of UB-851 and Eprex®CompletedNCT02708914Phase 3
- To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male VolunteersStatus unknownNCT02580006Phase 1
- Erythropoietin in Premature Infants to Prevent EncephalopathyTerminatedNCT02550054Phase 2
- Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)TerminatedNCT02522975Phase 4
- Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac SurgeryTerminatedNCT02210949Phase 4
- Allogeneic UCB Therapy With EPO in Children With CPCompletedNCT01991145Not applicable
- Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled TrialCompletedNCT01962571Phase 3
- Effect of Erythropoietin on the Incidence of Acute Kidney Injury Following Complex Valvular Heart SurgeryCompletedNCT01758861Phase 2
- Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.TerminatedNCT01695759Phase 3
- PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human RecombinantCompletedNCT01685359Phase 1
- PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.CompletedNCT01685333Phase 1
- PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.Status unknownNCT01664221Phase 1
- PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy SubjectsStatus unknownNCT01664195Phase 1
- Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.Status unknownNCT01624038Phase 2/3
- Efficacy Study of Epoetin Alfa in Friedreich AtaxiaCompletedNCT01493973Phase 2
- G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver DiseaseCompletedNCT01384565Phase 3
- Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver FailureCompletedNCT01383460Phase 3
- An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic SyndromesCompletedNCT01381809Phase 3
- Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced AnemiaCompletedNCT01374373Phase 4
- Study of Epoetin Alfa to Treat Anemia After Kidney TransplantationTerminatedNCT01290328Not applicable
- A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance TreatmentCompletedNCT01170078Phase 1
- Erythropoietin in Traumatic Brain Injury (EPO-TBI)CompletedNCT00987454Phase 3
- Erythropoietin Alfa in Elderly Subjects With Unexplained AnemiaWithdrawnNCT00954486Not applicable
- Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)WithdrawnNCT00869856Phase 3
- Characteristic Study on Chinese Patients With Multiple SclerosisStatus unknownNCT00818103Not applicable
- Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm ModelStatus unknownNCT00691613Not applicable
- Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal FailureCompletedNCT00676234Phase 2
- EPOMI Study: ErythroPOietin in Myocardial InfarctionCompletedNCT00648089Phase 2
- A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney DiseaseCompletedNCT00641589Phase 1